Pediatric uses of valacyclovir, penciclovir and famciclovir.
Dekker
C L
CL
Stanford University School of Medicine, Stanford, CA, USA.
Prober
C G
CG
D015075:2-Aminopurine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000212:Acyclovir / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D002648:Child; D017277:Drug Approval; D000077595:Famciclovir; D006147:Guanine; D006566:Herpesviridae Infections / Q000188:drug therapy*; D006801:Humans; D007121:Immunocompetence; D014481:United States; D014486:United States Food and Drug Administration; D000077483:Valacyclovir; D014633:Valine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use*
D000998:Antiviral Agents; C053539:penciclovir; D015075:2-Aminopurine; D006147:Guanine; D014633:Valine; D000077483:Valacyclovir; D000077595:Famciclovir; D000212:Acyclovir